SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19
PerkinElmer
JUNE 3, 2022
Viral protease inhibitors that block enzymes critical for viral replication have long been used in the treatment of human immunodeficiency (HIV) and hepatitis C viruses. Researchers are now studying the potential of protease inhibitors for the treatment of SARS-CoV-2. For research use only. Not for use in diagnostic procedures.
52 
Let's personalize your content